Communications

Analyzing how AI startups are copying websites to train systems that could replace white-collar workers, Prof. Robin Feldman explains these actions may violate copyright law, but companies are “shooting first and asking questions later.”

In an opinion piece, Prof. Dorit Reiss warns that changing federal guidance on newborn Hepatitis B vaccines could put children at greater risk, arguing the advisory board’s vote reflects bias and a departure from evidence-based decision making.

Noting that government fusion centers quietly collect broad personal data with little oversight, Nicole Ozer of the Center for Constitutional Democracy argues this surveillance model threatens civil liberties. She urges greater transparency and accountability.

Prof. Robin Feldman explains the potential litigation strategy behind Novo Nordisk suing smaller telehealth companies for selling cheaper versions of its weight-loss drug Wegovy.

Analyzing the Trump administration’s efforts to cancel more than $4 billion in foreign aid, Prof. Zachary Price highlights how a litigation strategy focused on technical arguments can yield narrow wins that cumulatively increase executive power.

Prof. Dorit Reiss says the Trump administration’s termination of funding for mRNA vaccines and treatments will “deter innovations.” Reiss was among the experts who say the decision will harm the nation’s ability to stop pandemics.

Prof. Kate Weisburd discusses the limitations, both practical and societal, of relying on GPS ankle monitors for youths in a long-form piece on teens in Washington, D.C.